Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 10.05%, which has investors questioning if this is right time to ...
Hangzhou, P.R.China 5 Department of Surgical Oncology ... lijun2009{at}zju.edu.cn Objective Raf kinase inhibitor protein (RKIP) appears to control cancer cell metastasis and its expression in colonic ...
2d
Investor's Business Daily on MSNArcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...
Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.
Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The cyclic AMP/protein kinase A (cAMP/PKA) pathway is one of the most common and versatile signal pathways in eukaryotic cells. A-kinase anchoring proteins (AKAPs) target PKA to specific substrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results